Publications

5674 Results

Long term efficacy and QOL data of chemohormonal therapy (C-HT) in low and high volume hormone naïve metastatic prostate cancer (PrCa): E3805 CHAARTED trial

Authors
C Sweeney;Y-H Chen;G Liu;M Carducci;D Jarrard;M Eisenberger;Y Wong;L Patrick-Miller;N Hahn;M Kohli;M Conney;R Dreicer;N Vogelzang;J Picus;D Shevrin;M Hussain;J Garcia;R Dipaola
Journal / Conference
Annals of Oncology vol. 27, 2016 Supp 6,abst. 720PD; European Society for Medical Oncology (October 7-11, 2016, Copenhagen, Denmark), (Annals of Oncology), poster
Year
2016
Research Committee(s)
Genitourinary
Study Number(s)
CTSU/E3805

Lung-MAP (S1400) Lung Master Protocol: Accrual and Genomic screening updates

Authors
V Papadimitrakopoulou;M Redman;D Gandara;F Hirsch;P Mack;H Borghaei;C Langer;J Wade;M Edelman;K Albain;P Lara;C Aggarwal;M Socinski;S Gettinger;L Bazhenova;S Malik;V Miller;S McDonough;E Sigal;K Kelly;R Herbst
Journal / Conference
World Conference on Lung Cancer (Dec 4-7, 2016,Vienna, Austria), oral
Year
2016
Research Committee(s)
Lung
Study Number(s)
S1400

Role of KRAS mutation status in NSCLC patients treated on S0819, a phase II trial of chemotherapy with or without cetuximab

Authors
P Mack;J Moon;R Herbst;ES Kim;T Semrad;M Redman;RA Tsai;L Solis;J Gregg;S Hatcher;M Varella Garcia;F Hirsch;C Blanke;K Kelly;D Gandara
Journal / Conference
World Conference on Lung Cancer (Dec 4-7, 2016,Vienna, Austria); poster
Year
2016
Research Committee(s)
Lung
Study Number(s)
S0819

Afatinib with or without cetuximab for first-line treatment of advanced EGFR-mutant NSCLC: Interim Results of SWOG S1403

Authors
S Goldberg;J Moon;R Lilenbaum;K Politi;M Melnick;T Stinchcombe;L Horn;E Chen;J Miao;M Redman;K Kelly;D Gandara
Journal / Conference
World Conference on Lung Cancer (Dec 4-7, 2016,Vienna, Austria); poster
Year
2016
Research Committee(s)
Lung
Study Number(s)
S1403

A phase II study of dasatinib and dexamethasone as primary therapy followed by hematopoietic cell transplantation for adults with Philadelphia chromosome-positive acute lymphoblastic leukemia: CALGB Study 10701 (Alliance)

Authors
MJ Wieduwilt;J Yin;M Wetzler;G Uy;BL Powell;J Kolitz;M Liedtke;W Stock;J Beumer;R Mattison;A Halvorson;S Devine;R Stone;R Larson
Journal / Conference
Blood 2016 128:2782; American Society of Hematology Annual Meeting (December 3-6, 2016, San Diego, CA), poster
Year
2016
Research Committee(s)
Leukemia
Study Number(s)
CTSU/C10701

Reply to H.J.A. Adams et al and E.A. Hawkes et al [correspondence re S0816]

Authors
O Press;J Friedberg
Journal / Conference
Journal of Clinical Oncology; DOI: 10.1200/JCO.2016.69.7979; online before print October 28, 2016
Year
2016
Research Committee(s)
Lymphoma
PMID
PMID27069074
PMC
n/a - correspondence
Study Number(s)
S0816

Long-term follow-up of SWOG S0816: Response-adapted therapy of advanced stage Hodgkin lymphoma using early interim FDG-PET imaging

Authors
JW Friedberg;H Li;H Schoder;D Strauss;CH Moskowitz;M Leblanc;L Rimsza;N Bartlett;A Evens;E Mittra;AS LaCasce;J Sweetenham;P Barr;M Fanale;M Knopp;A Noy;E Hsi;J Cook;M Lechowicz;R Gascoyne;JP Leonard;BS Kahl;B Cheson;R Fisher;OW Press
Journal / Conference
Haematologica Oct 2016 101:19 (abst T003); International Symposium on Hodgkin Lymphoma (Oct 22-25, 2016, Cologne, Germany), oral
Year
2016
Research Committee(s)
Lymphoma
Study Number(s)
S0816

American Society of Clinical Oncology statement: human papillomavirus vaccination for cancer prevention [Review; Special Recommendations Article]

Authors
HH Bailey;LT Chuang;NC Dupont;C Eng;L Foxhall;JK Merrill;DS Wollins;CD Blanke
Journal / Conference
Journal of Clinical Oncology May 20;34(15):1803-1812
Year
2016
Research Committee(s)
Prevention, Screening, and and Surveillance
PMID
PMID27069078; PMC Journal - In Process
PMC
PMC n/a Special Article

Evolving recommendations on prostate cancer screening [Review]

Authors
OW Brawley;IM Thompson;H Gronberg
Journal / Conference
American Society for Clinical Oncology Educational Book 35:e80-7
Year
2016
Research Committee(s)
Cancer Control, Prevention, Screening, and and Surveillance
PMID
PMID27249774
Study Number(s)
SWOG-9217

Selenium and prostate cancer: analysis of individual participant data from fifteen prospective studies

Authors
NE Allen;RC Travis;PN Appleby;D Albanes;MJ Barnett;A Black;H Bueno-de-Mesquita;M Deschasaux;P Galan;G Goodman;P Goodman;M Gunter;M Heliovaara;J Helzlsouer;BE Henderson;S Hercberg;P Knekt;LN Kolonel;C Lasheras;J Linseisen;EJ Metter;M Neuhouser;A Olsen;V Pala;EA Platz;H Rissanen;ME Reid;M Schenk;M Stampfer;P Stattin;C Tangen;M Touvier;A Trichopoulou;P van den Brandt;TJ Key
Journal / Conference
Journal of the National Cancer Institute Jul 6;108(11)
Year
2016
Research Committee(s)
Cancer Control, Prevention, Screening, and and Surveillance
PMID
PMID27385803
PMC
PMC5241899
Study Number(s)
S0000, SWOG-9217